Patient Power®
Get Email Alerts!
Health Topics
View all Health Topics >
6/12/12

ASCO Myeloma Update: More Promising Medicines on the Way

Dr. James Berenson gives his perspective on the latest drug development updates from ASCO 2012

Health Topics: Multiple Myeloma

Get Email Updates:

Get updated automatically when new content about Multiple Myeloma has been posted.
Privacy Policy
Multiple Myeloma

Experts & Guests

James Berenson, M.D. James Berenson, M.D.
Founder, President and Medical and Scientific Director, Institute for Myeloma and Bone Cancer Research
James Berenson, M.D. is the Founder, President & Chief Executive Officer of the Institute for Myeloma and Bone Cancer Research. Dr. Berenson has specialized in research related to myeloma and metastatic bone disease both in the basic and clinical areas for more than 25 years. He has been involved in many of the major breakthroughs that have brought new treatments for... more >

Related Programs

Dr. Paul Richardson provides an update on drug development from ASCO 2012

Watch Now

Dr. James Berenson helps patients understand new FDA recommendations regarding the use of lenalidomide and an increased risk of secondary cancers.

Watch Now

Dr. Robert Orlowski explains the basics of elotuzumab.

Watch Now